Abstract
Assessing the inducibility of CYP3A4 by various xenobiotics can predict potential drug interactions. In the present investigation, human hepatoma cells were stably integrated with either the CYP3A4 enhancer region and a luciferase reporter gene or the CYP3A4-luciferase construct and the human pregnane X receptor (PXR). Several colonies containing one to three copies of luciferase per cell were identified by Southern blot analysis. Those transformants producing high luciferase activity in response to rifampicin were used to standardize a 96-well plate screening system with minimal inter- and intraplate variability. Standardization also consisted of assessing viability of cells cultured in medium containing various serum concentrations. In cells maintained for 48 h in medium with less than 5% serum, a significant (p < 0.01) decline was observed in viability accompanied by altered induction. A defined serum-free medium also produced less viable cells but did not alter the inductive response. Treatment of transformants with various concentrations of rifampicin produced a dose-response curve with maximal induction at 10 μM (5.6 ± 0.18- and 2.1 ± 0.3-fold above dimethyl sulfoxide (DMSO)-treated cells in transformants with and without PXR, respectively). Of additional agents examined for their ability to induce CYP3A4, omeprazole (200 μM) was the most potent inducer (12.8 ± 1.9- and 2.4 ± 0.2-fold above DMSO-treated cells in transformants with and without PXR, respectively). Mifepristone and mevastatin produced modest induction (∼3-fold) in the cell line containing exogenous PXR, but produced less than 1.2-fold increases in cells lacking PXR. Thus, only potent inducers can be identified in the cell line without PXR. In contrast, cells containing the receptor can be used to rank CYP3A4 induction. Because a high volume of chemicals can be readily and accurately screened for their ability to induce CYP3A4 with this format, such a system could be valuable in the initial stages of preclinical drug development.
Footnotes
-
This research was supported by National Institutes of Health Grant GM58287 (to M.-F.Y.).
-
DOI: 10.1124/jpet.102.038653
- Abbreviations:
- P450
- cytochrome P450
- PXR
- pregnane X receptor
- PCN
- pregnenolone 16α-carbonitrile
- bp
- base pair(s)
- hPXR
- human pregnane X receptor
- DMSO
- dimethyl sulfoxide
- PXRE
- pregnane X response element
- DMEM
- Dulbecco's modified Eagle's medium
- FBS
- fetal bovine serum
- HMM
- hepatocyte maintenance media
- TCDD
- 2,3,7,8-tetrachlorodibenzo-p-dioxin
- SF
- serum-free media
- RLU
- relative light unit
- OMP
- omeprazole
- HTS
- high throughput screening
- CAR
- constitutive androstane receptor
- Received May 9, 2002.
- Accepted June 20, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|